5 years ago

Permitted Daily Exposure (PDE) of the Androgen Receptor Antagonist Flutamide.

Zacharia LC
This report aims to determine the Permitted Daily Exposure (PDE) of flutamide, an androgen receptor blocker, as directed by guideline EMA/CHMP/CVPM/SWP/169430/2012 that came into effect on June 2015. A literature review was conducted to identify toxicity studies of flutamide. Hazards and sensitive endpoints were determined. Based on the No Adverse effect Level (NOAELs) and Lowest Observed Adverse effect Levels (LOAELs) reported from both reproductive, developmental and 28 day toxicity studies the PDE was calculated. Most of the toxicity studies converge toward a NOAEL of 1 mg/kg/day that translates to a PDE of 0.1 mg/day. However, taking into consideration the worst case scenarios for additional safety a PDE of 0.025 mg/day (25 μg/day) was calculated based on a reported NOAEL of 0.25 mg/kg/day. A PDE of 0.05 mg/day (50 μg/day) was also calculated from reproductive/developmental toxicity studies, which is in close agreement with the PDE from the 28 day toxicity studies. Considering the lowest PDE of 0.025mg/day, residual flutamide at this dose is unlikely to pose any risk to humans. Non monotonic dose response (NMDR) effects of flutamide were not supported by literature. Oral route of administration was considered.

Publisher URL: https://www.ncbi.nlm.nih.gov/pubmed/28666357

DOI: PubMed:28666357

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.